Form 4: Cabot CEO Sean Keohane Reports Equity Awards
Insider Transaction Report
Cabot Corp's President and CEO, Sean D. Keohane, reported the acquisition of common stock and employee stock options, alongside a disposition for tax purposes, as part of his compensation.
Summary
- Sean D. Keohane, President and CEO of Cabot Corp, acquired 32,630 shares of common stock at a price of $0 on November 19, 2025.
- An additional 30,932 shares of common stock were acquired at $0 on November 19, 2025, consisting of performance-based units earned for fiscal year 2025, with 22,630 of these shares remaining subject to time-based vesting.
- Keohane disposed of 10,338 shares of common stock at a price of $59.76 on November 19, 2025, likely for tax withholding related to the vesting of equity awards.
- Following these transactions, Keohane directly beneficially owns 404,134 shares of common stock and indirectly owns 13,933.1846 shares through the Corporation's 401(k) Plan.
- Keohane was granted 122,114 Employee Stock Options (Right to Buy) with an exercise price of $59.76 on November 19, 2025.
- These options vest over a three-year period: 30% on November 19, 2026, 30% on November 19, 2027, and 40% on November 19, 2028, and expire on November 18, 2035.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive as it reflects routine executive compensation, including significant equity grants, which generally aligns management's interests with shareholders. There are no negative surprises, and the disposition is for tax purposes, which is standard.
Positives
- The acquisition of 63,562 shares of common stock and 122,114 employee stock options at a $0 cost (for shares) or as a grant (for options) represents significant equity compensation for the CEO.
- The equity grants align the CEO's financial interests with those of shareholders, incentivizing long-term performance and value creation.
- The performance-based units earned for fiscal year 2025 suggest the company met certain performance targets.
Negatives
- The disposition of 10,338 shares of common stock at $59.76 reduces the CEO's direct shareholding, although this is a common practice for tax withholding upon vesting of equity awards.
Risks
- The value of the acquired common stock and stock options is subject to market fluctuations, posing a risk to the ultimate realized value of the compensation.
- The vesting schedules for both the performance-based units and employee stock options mean that a portion of the compensation is not immediately realized and is contingent on continued employment and future performance.
Future Outlook
The vesting schedules for the performance-based units and employee stock options indicate a long-term incentive structure designed to retain the CEO and align his interests with the company's future performance through November 2028 and the option expiration in November 2035.
Industry Context
The reported transactions reflect standard executive compensation practices within publicly traded companies, where a significant portion of executive pay is often tied to equity awards to incentivize long-term performance and align management interests with shareholder value. The use of performance-based units and time-based vesting is a common mechanism to achieve these objectives.
Comparison to Industry Standards
- Equity-based compensation, including stock grants and stock options with vesting schedules, is a widely adopted practice across various industries for executive incentives.
- The structure of performance-based units tied to fiscal year performance is a common approach to link executive pay directly to company results.
- The disposition of shares for tax withholding upon vesting is a routine event in executive compensation plans and is consistent with industry norms.
Stakeholder Impact
- Shareholders: The equity grants align the CEO's long-term interests with shareholder value creation, potentially leading to more focused strategic decisions.
- Employees: The compensation structure for the CEO may set a precedent or reflect the company's overall approach to executive incentives.
Next Steps
- The vesting of 22,630 performance-based common stock units will occur over time.
- The employee stock options will vest in three tranches on November 19, 2026, November 19, 2027, and November 19, 2028.
- The CEO may exercise the vested employee stock options at any time before their expiration on November 18, 2035.
Key Dates
| Date | Description |
|---|---|
| 11/19/2025 | Transaction date for acquisition of common stock, disposition of common stock, and grant of employee stock options. |
| 11/19/2026 | First vesting date for 30% of the employee stock options. |
| 11/19/2027 | Second vesting date for 30% of the employee stock options. |
| 11/19/2028 | Third vesting date for 40% of the employee stock options. |
| 11/18/2035 | Expiration date for the employee stock options. |
| 11/21/2025 | Date the Form 4 was signed and filed. |
Recommendation
holdThis Form 4 filing reports routine executive compensation, including equity grants and a disposition for tax purposes. It does not contain new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment recommendation. The transactions are expected and align with standard corporate governance practices for executive incentives, thus maintaining a 'hold' stance based solely on this filing.
Keywords
Cabot Corp, CBT, Form 4, Insider Transaction, Executive Compensation, Stock Options, Equity Awards, Performance Units, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.